Shanghai Fosun Pharmaceutical (Group) Co Ltd 2020 Sustainability Report
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2020
Type: Sustainability Report
Pages: 142
The report highlights Fosun Pharma's extensive COVID-19 response, including development of an RT-PCR detection kit and collaboration with BioNTech on the BNT162b2 mRNA vaccine. It reports a year-end workforce of 32,258 employees and zero confirmed occupational disease and major injury incident. Environmental performance included 7,655,768 GJ of total energy consumption and 827,858 tons of total carbon emissions in the detailed 2020 table, alongside energy-saving measures that reduced reported carbon emissions by 7,399 tons.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.